VANCOUVER, Nov. 8, 2011 /CNW/ - Neovasc Inc. (TSXV: NVC) today announced
that chief executive officer Alexei Marko will present at the upcoming
Lazard Capital Markets 8th Annual Healthcare Conference at 4:00 PM EST
on November 15, 2011. The conference will be held at the Pierre Hotel
in New York City.
The company's presentation will be webcast live. It can be accessed at
the Investors section of the Neovasc website at www.neovasc.com or at http://wsw.com/webcast/lz11/nvcif.pk/. An archived version of the webcast will be available for at least 30
days after the conference.
For more information about the Lazard 8th Annual Healthcare Conference,
About Neovasc Inc.
Neovasc Inc. is a specialty medical device company that develops,
manufactures and markets products for the rapidly growing
cardiovascular marketplace. Its products include the Neovasc Reducer™
for the treatment of refractory angina, the Tiara™ technology in
development for the transcatheter treatment of mitral valve disease and
a line of advanced biological tissue products that are used as key
components in a variety of third-party medical products, such as
vascular surgical patches and transcatheter heart valves. For more
information, visit www.neovasc.com.
SOURCE Neovasc Inc.
For further information:
| Corporate contact: |
| U.S. media & investor contact: |
GendeLLindheim BioCom Partners